A phase I study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) plus platinum-based doublet chemotherapy (PT-doublet) in chemotherapy-naive non-small cell lung cancer (NSCLC) patients (pts) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Rizvi, Naiyer A
  • Antonia, Scott J
  • Chow, Laura Quan Man
  • Brahmer, Julie R
  • Juergens, Rosalyn
  • Borghaei, Hossein
  • Shepherd, Frances A
  • Laurie, Scott Andrew
  • Gerber, David E
  • Goldman, Jonathan Wade
  • Shen, Yun
  • Harbison, Christopher
  • Alaparthy, Suresh
  • Chen, Allen C
  • Gettinger, Scott N

publication date

  • May 20, 2013